Contraction/conduction and cardiac glycosides Flashcards
Contractility
- Force of contraction
- Increase preload=Increase contractility
- Decrease afterload=Increase contractility
- Contractility is independent of loading
SV factors
- Contractility
- Preload
- Afterload
Fast AP
- aka muscle/Long AP
- Ventricular Myocyte
- His-Purkinje System, Atrial and ventricular muscle
- Mediated by Na+ influx
- Resting membrane potential is lower than nodal
- prevents hyperexcitabilty
- wont spontaneously fire
- wait for signal from nodal tissue
- Phase 0,1,2=QRS
- Phase 3=T wave
- Phase:
- Phase 0=depolariation
- Na+ Channel opens, Na+ influx
- Upstroke; Increase permeability of Na+
- Phase 1: partial repolarization
- Na+ Channel closes, K+ channel opens
- K+ eflux
- Phase 2: Plateau phase=K+-mediated
- Ca2+ Channel opens, (Fast K+ Channel close)
- Ca2+ Influx (K+ efflux)
- Phase 3: Ca2+ Channel close, Slow K+ channel open
- K+ efflux
- Phase 4: Resting potential
- stable potential; K+ eflux
- Phase 0=depolariation
- Class I and III antiarrhythmics
Fast AP:Absolute refractory period
- aka effective refractory period
- Under no circumstance will heart fire/depolarize
- phase 0-2 of Fast AP
Fast AP: Relative Refractory Period:
- Mostly refractory but if you come in w/a strong enough stimulus=you can trigger a resopnse
- PHASE 3
- Problem: Long QT Syndromes
- arrival of T wave is delayed (repolarization delayed)
- common source for dangerous arrhythmias
- occurs due to dysfunctional K+ channels
Cardiac Glycosides: Pharmocological effects:
- Improves contractility
- Increase CO
- Increase Renal BF
- Decrease Blood Volume and edema
- Decrease preload
- Sensitize the carotide sinus (Both causes Decrease HR)
- Decrease Sympathetic tone
- Increase Vagus tone
- Vasodilation
Cardiac Glycosides: MOA:
- Inhibition of Na+/K+ ATPase causes Increase in intracellular Na+
- 2 possible mechanisms
- Inhibits Ca2+/Na+ exchange–>Less Ca2+ extrusion–> Increase Ca2+ intracellular
- Stimulates Ca2+/Na+ exchanger–> Na+ eflux, Ca2+ influx
- Both Cause Increase of Ca2+ intracellular–>Stimulates Contractile proteins
- Increase Force of contraction (contractility)
Cardiac Glycosides: Electrical effects
- Inhibition of pump redistributes Na+, Ca2+, and K+
- Depolarizes Cells
- Increase ectopic automaticityin heart
- due to Ca2+ Loading
- Increase refractory period early
- Decrease conduction velocity due to increase vagal tone
Effects of Digoxin on electrical properties of cardiac tissue: SA Node etc:
Therapeutic dose vs toxic doses
- SA Node
- Therapeutic: Decrease rate
- Toxic: Decrease rate
- Atrial Muscle
- Therapeutic:
- Decrease refractory period
- Toxic:
- Decrease refractory period
- arrhythmias
- Therapeutic:
- AV node:
- Therapeutic:
- Decrease conduction velocity
- Increase refractory period
- Toxic:
- Decrease refractory period
- Therapeutic:
- His-purkinje/ Ventricles:
- Therapeutic:
- Slight decrease refractory period
- Toxic:
- extrasystoles
- tachycardia
- Fibrillation
- Therapeutic:
- ECG:
- Therapeutic:
- Increase PR interval
- Decrease QT interval
- Toxic:
- Tachycardia
- Fibrillation
- Cardiac arrest with really high doses
- Therapeutic:
Digoxin: Pharmokinetics:
Onset, optimal serum levels, GI Absorption, Plasma half life, Daily excretion, Plasma protein, excretion
- Onset of action: 10-30 mins
- Optimal serum levels:
- 0.5-2.5ng/mL
- GI Absorption:
- Tablets: 60-80%
- Lanoxicaps: 90-100%
- Plasma Half Life
- 35-40 hours
- Load dose
- 35-40 hours
- Daily excretion:
- 30%
- kidney disease=modify dose
- Plasma protein Binding:
- 20-40% excreted out
- Excretion:
- kidney
- CCR=Creatine clearance level: Assess in elderly to determine if you need to modify dose
Digoxin: Toxicities:
- High Risk of Toxicity:
- 20-25% hospitalized patients
- Greater risk in advanced heart disease
- Antidote for Overdose:
- Digoxin immune fab
- Cardiac Toxicities:
- Primary toxic effect is arrythmias
- can be sinus block, AV block, AV junctional arrythmias
- casues:
- premature ventricular contractions (most common)
- Tachycardia
- Ventricular Fibrillation
- Primary toxic effect is arrythmias
- Non-cardiac toxicities
- Fatigue, muscles weakness
- GI
- Anorexia
- Nausea-cenrally mediated
- common early sign
- CNS:
- difficulty walking
- confusion
- halucinations
- restlessness
- insomnia
- drowsiness
- Psychoses
- Vision:
- blurred
- photophobia
- alterations in color=objects appear green or yellow
- some make pats develop gynectomastia
- due to androgenic effect
Digoxin: Factors that increase conc.
- High dose (received wrong dose)
- Reduced renal fxn
- decreased excretion
- Altered distribution
- elderly-lean body mass
Digoxin: DDIs
- Diuretics–>produce hypokalemia
- decrease Plasma K+ and Mg2+
- Increase serum Ca2+
- Increase Toxicity
- Antacids: Decrease absorption
- Decrease K+
- Corticosteroids:
- decrease serum K+
- Increase toxicity
What maintains Resting membrane potential in fast action potentials?
- K+ Leak channels
- Na+/K+ ATPase
Mechanism of Fast APs
- Nodal AP enters from adjacent cell
- Voltage gaded Ca2+ channels open, Ca2+ enters
- Ca2+ induces Ca2+ release through ryanodine receptor channels (RYR) from sarcoplasmic reticulum
- Local release causes Ca2+ spark
- Summed Ca2+ spark creates a Ca2+ signal
- Ca2+ ions bind to troponin to initiate contraction
- Relaxation occurs when Ca2+ Unbinds from Troponin
- Ca2+ is pumped back into sacroplasmic reticulum to storage
- Ca2+ is exchanged with Na+
- Na+ gradient is mainted by the Na+/K+ ATPase
How do we regulate force of contraction in the heart and steps:
Sympathetic stimulation (Increase Contractility and HR)
- B-adrenergic stimulation leads to: (NE binds)
- phosphorylationof membrane Ca2+ channels causes them to be more open–>increasing transmembrane Ca2+ influx
- Phosphorylation of Troponin-1 inhibits Ca2+ binding to troponin-C, making it easier to remove Ca2+ from binding sites
- Increase Ca2+ turnover into contractile proteins
- Phosphorylation of Phospholamban, which removes inhibitiory control on sarcoplasmic reiculum ATPase, and increase Ca2+ uptake into SR
- NET Result:
- increased force of contraciton
- decreased contraction time caused by increase rate of contraciton and rate of relaxation
- Cardiac Glycosides=downside
- inhibit Na+/K+ pump which results accumulation of Na+ intracellular is it effects all Na+/K+ ATPase pumps thorughout the body which can cause hyperkalemia
- Na+ Intracellular Increase
- Ca2+ intracellular increase
- K+ Extracellular increase (hyperkalemia)
- Increase contractility
- inhibit Na+/K+ pump which results accumulation of Na+ intracellular is it effects all Na+/K+ ATPase pumps thorughout the body which can cause hyperkalemia
Control of BP
- Cardiovascular system:
- Cardiac Output:
- Preload
- contractility
- Afterload
- HR
- Cardiac Output:
- Vascular
- Vascular Resistance
- sympathetic tone
- Autoregulatory factors
- Vascular Resistance
- Kidneys: Long term
- fluid volume regulated by renal control
How to figure out preload from system
- Preload
- preload=filling of the heart during diastole
- Increase Preload=Increase Contractility
- EDV: End Diastolic Volume
- best indicator for how full the heart is before contraciton
- most accurate but hard to measure=need cardiac ultrasound
- EDP: End Diastolic pressure
- measured by ventricular cather
- tells us what preload is
- CVP-Central Venous Pressure
- most common to assess preload
- Equilibrates with the ventricle
- By the end of diastolic filling, the EDP=CVP
- no catheter needed
- Look for jugular vneous distention, bc close to inferior vena cava=reflect CVP
- How much distention you see give you how high CVP is:
- How high above the clavicular line you see the jugular vein OR
- how high pulse in jugular vein
- used to determine whether your heart is capable of moving the fluid
- Incrrease CVP=HF
- preload=filling of the heart during diastole
What can make Central Venous Pressure increase?
Contractility:Performance measures of the system
- SV-need cardiac ultrasound
- CO-need cardiac ultrasound
- SBP-systolic Blood pressure
- pulse amplitude (pulse pressure)=SV
- Pulse pressure=SBP-DBP
- Increase PP=Increase SV
- EF: Ejection fraction
- radiograph image or ultrasound
- What % of starting EDV (end diastolic volume) Was ejected
- EF= SV/EDV
- normal: 50-60%; decreases in sick hearts
- used most common
Afterload of system to determine contractiility:
- Afterload=Resistance
- DBP=diastolic blood pressure
- best indicator for resistance
- Increase TPR=Increase Afterload
- DBP=diastolic blood pressure
Starling law of Heart
How to evaluatae contractility
- Starling curves=loading @ constant contractilty/afterload
- relationship b/w preload and force
- Increased EDV (Stretch) should increase the force being produced (contractility)=Increase SV
- Normal resting values:
- Force: indicated by SV
- 70mL
- Stretch=indicated byEDV
- 135mL
- Force: indicated by SV
- Increase filling(preload)–> Increase performance (Force)
- Indices of preload (x-axis)
- EDV
- EDP
- CVP
- Indices of performance (Y-axis)
- SV
- LVSP
- CO
Diuretics:
- casues body to lose water (decrease blood volume) and urinate more
- most common for BP control:
-
Thiazide diuretics: (Thiazides)
- first line
- long term use shows decreased reactivity of vessels
- Looop Diuretics:
- Furosemide
- Congestive Heart Failure
- Potassium Sparing diuretics
- 3rd line w/BP control
-
Thiazide diuretics: (Thiazides)
Drugs that interrupts the RAAS
really effective when plasma renin activity is high
- Angiotensin-Converting Enzyme Inhibitors
- ACE inhibitors
- Angiotensin Receptor BLockers (ARBs)
- Direct Renin Inhibitor:
- Aliskerin
- Aldosterone Antagonist
ACE inhibitors:
- suffix
- admin
- metabolism
- Side effects
- DDIs
- miscellaneous
- -pril
- inhibits ACE
- Admin: Oral
- except enalaprilat
- don’t have to have food in system when you take
- Metabolism:
- excreted renally
- Advise to take at night before bed to reduce risk of hypotension and maximize effictiveness
- Side effects:
-
COUGH
- iron supplement dampens this effect
- Angioneurotic edema
- more common in african americans
- Hyperkalemia
- applies to B-blockers, ARBS, DRIs
- Acute renal failure in the presence of renal artery stenosis
- Skin rash; abnormal taste sensation (iron)
- Fetal harm due to exposre to ace inhibitors during 1st trimester
- Never use any of the RAAS inhibitors
-
COUGH
- DDIs:
- Diuretics
- potassium sparing diuretics
- Potassium supplements
- Lithium
- ACEI can raise lithium levels
- NSAIDS
- can inhibit antiHTN effects by retention of salt and water
- Diuretics
- Additional Benefits:
- slow the progression of:
- diabetes-induced nephropathy (proeinuria>300mg/day)
- diabetes-induced retinopathy independent of BP lowering bc:
- __Diabetes causes Increased VEGF
- Angiotensin II interacts with VEGF=retinopathy
- slow the progression of:
Current recommendations for RAAS drug prescription
- ACEIs and ARBS are the drugs of choice to prevent long-term cardiac remodeling
- Use DRIs if side effects are not tolerated
ARBS:
- suffix
- MOA
- admin
- metabolism
- Side effects
- DDIs
- miscellaneous
- -sartan/artan
- MOA:
- Angiotensin Type 1 antagonists (AT1 antagonists)
- Blocks AT1 receptor
- works similar to ACEI but:
- ACEIs are decreasing Ang II
- Block AT1 receptor where Ang II would bind
- Downstream effects:
- dilation of arterioles and veins
- reduce excretion of K+
- decrease release of aldosterone
- Increase renal excreetion of Na+ and Water follows
- Do not inhibit ACE
- DO not increase levels of Bradykinin
- Side effects:
- NO COUGH-biggest advantage over ACEIs
- same as ACEIs
- DDIs:
- Same as ACEIs
- Losartan (Cozaar
DRIs
Direct Renin Inhibitor=Aliskerin
- Admin: Oral
- MOA: Binds to the active site on renin
- No cough
- angioedema
- NOT 1st line agent
- Newer drug and more expensive
- use if patient has side effects with angioedema from ARBs & ACEIs
Calcium Channel Blockers (CCBs)
- Aka Calcium channel antagonists
- Slow calcium blockers
- Calcium entry blockers
- Calcium channels
- critical role in the function of vascular smooth muscle and heart
- 2 main groups
- Nodihydropyridines: Verapamil & Diltiazem
- acts on both VSM and heart
- Dihydropyridines: Nifedipine
- act on VSM only
- Nodihydropyridines: Verapamil & Diltiazem
- MOA:
- prevent calcium ions from entering the cell
- greatest effect on heart and blood vessels
- effective in low renin HTN
- Physiologic fxns and consequences of blockade
- VSM
- regulate contraction= Decrease sensitivity of constriciton of vessels
- CCBs act selectively on arterioles and arters, and arterioles of heart
- no significant effect on veins
- Heart:
- Myocadrium: Ca2+ increases Contractility
- inotropy
- SA node: Decrease HR
- AV node: decrease velocity of conduction
- coupling Calcium channels to Beta1-adrenergic receptors
- when B1 is activated, calcium influx is increased
- Myocadrium: Ca2+ increases Contractility
- VSM
- Adverse effects:
- Constipation
- dizziness
- facial flusing
- headache
- edema of ankles and feet
- heart block-can report a heart attack on ECG
- DDI:
- Beta-adrenergic blocking agents
- synergistic effect
- Food
- grape fruit juice (anything citrisy)
- CYP3A4
- Digoxin
- Beta-adrenergic blocking agents
- Toxicity:
- severe hypotension
- Bradycardia and AV block
- Ventricular tachydysrhytmias=Fatal heart syndrome
Similarity b/w CCBs and Beta-Blockers
Have same effects:
- Reduce force of contraction
- slow HR
- suppress conduction through AV node
DO NOT GIVE IN COMBO=SYNERGISTIC EFFECT
-can introduce new arrythmias
Nondihydropyridines:
- Type of CCB
- Verapamil & Diltizaem
- Admin:
- oral or IV
- Metabolism: Extensive 1st pass metabolism
- MOA-act on VSM and heart
- blacks Ca2+ channels
- Both drugs act like one another=hemodynamic effects
- vasodilation
- reduced arterial pressure
- increased coronary perfusion
- Major therapeutic uses
- angina pectoralis
- essential HTN
- cardiac dysrhythmias
Dihydropyridines:
Type of CCB
- Nifedipine/Amlodipine
- -dipine
- MOA: Acts on VSM
- Blocks Ca2+ channels
- Hemodynamic effect
- lowers BP
- increases HR and contractile force
- Therapeutic use:
- angina pectoralis
- HTN
- relieve migraine headache
- suppress preterm labor
- Adverse effects:
- gingival hyperplasia
- reflex tachycardia
- DDI
- Beta-adernergic blockers (Beta blockers)
- often combined with beta-blocker to reduce reflex tachycardia
- Beta-adernergic blockers (Beta blockers)
- Long-acting Nifedipine reduces reflex tachycardia and is more useful in treating essential HTN than original short-acting
Antihypertensive drugs: SNS target in CNS
- Primarily target the alpha 2 receptors (Adrenergic 2) in the CNS
- inhibit SNS
- CNS receptors:
- B1 (Beta 1)
- increases SNS activity=vasoconstriction
- alpha 2 (a2)
- inhibits SNS activity=vasodilation
- B1 (Beta 1)
- Outcome:
- reduciton in postganglionic nerve activity (NE) and adrenal medulla (NE/E)
- leads to a reduction in vascular resistance (BP
- Positive and Negative Feedback control of NE release @ sympathetic nerve termina
- NE binds A2 and inhibits teh SNS
- Negative feedback
- NE binds to Beta receptors=Increase SNS activity
- positive feedback
- NE binds A2 and inhibits teh SNS
Beta-Adrenoreceptor Blockers
Aka Beta Blockers
- -olol
- Slows HR and Lowers BP
- MOA: Block B1 adrenoreceptor (B1 receptor antagonist)
- Heart=Reduce CO and HR
- Kidney (B1)=reduced renin
- CNS: inhibits SNS
- BLood Vessels: Enhance endothelial synthesis of DGI2
- Adverse effects:
- Adverse lipid profile
- can mask or induce diabetes
- Hyperglycemia
- can mask or induce diabetes
- Excessive bradycardia (such as AV block), arrythmyia
- combo with CCBs
- Hyperkalemia
- Fatigue, depression, insomnia, CNS effects
- Adverse lipid profile
- Contraindications:
- Asthma
- don’t use non-cardioselective B-Blcokers
- can use cardioselective-hopefully only selects B1
- Diabetes
- Peripheral artery disease-challenged by Nebivolol/metoprolol
- Asthma
- DDIs:
- NSAIDs
- K-sparing diuretics
- CCBs–> nonodihydropyridine
- can use with Nifediipine
- Reasons:
- reduced hypotensive actions=inhibits PGI2 produciton
- Hyperkalemia
- bradycardia
- AV block
Slow AP
- SA node